Index of reports
> Cases with Anaemia (49)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 49 Next >>
Possible Kaletra side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21
Patient:
Reactions: Atrial Septal Defect, Jaundice, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Anaemia, Ascites, Hydrops Foetalis, Talipes
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in female
Reported by a physician from Russian Federation on 2012-08-17
Patient: female
Reactions: Umbilical Cord Abnormality, Anaemia, Placental Disorder, PRE-Eclampsia, Enterocolitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epivir
Indication: Product Used FOR Unknown Indication
Kaletra
Indication: HIV Infection
Start date: 2012-02-17
Kaletra
Nikavir
Indication: HIV Infection
Other drugs received by patient: Valcit; Elevit; Folic Acid; Kipferon; Erythromycin; Combivir; Wobenzym; Hexicon Suppositories; Trichopol; Acyclovir
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-16
Patient: male
Reactions: Agitation, Urinary Incontinence, Coma, Coma Scale Abnormal, Pyrexia, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, General Physical Health Deterioration, Encephalopathy, Faecal Incontinence, Convulsion, Respiratory Tract Congestion, Apathy, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Hyponatraemia, Cerebral Atrophy, White Blood Cell Disorder, Renal Failure, Hypoproteinaemia, Diarrhoea, Brain Abscess, Heart Rate Increased, Encephalitic Infection, Heart Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: df 10mg/ml
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Amikacin
Dosage: 900 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Cernevit-12
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Clarithromycin
Dosage: df 50mg/ml
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: df 80/20 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Myambutol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Nefopam
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven (Parenteral Nutrition)
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Prazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Rifabutin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Viramune
Indication: HIV Infection
Start date: 2012-03-01
End date: 2012-05-01
Other drugs received by patient: Propofol; Adavat
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-15
Patient: male
Reactions: Agitation, Urinary Incontinence, Coma, Pyrexia, Coma Scale Abnormal, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, Encephalopathy, Faecal Incontinence, General Physical Health Deterioration, Convulsion, Apathy, Respiratory Tract Congestion, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Cerebral Atrophy, Hyponatraemia, Renal Failure, White Blood Cell Disorder, Diarrhoea, Hypoproteinaemia, Heart Rate Increased, Brain Abscess, Encephalitic Infection, Heart Sounds Abnormal
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Acetaminophen
Dosage: df 10mg/ml
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Amikacin
Dosage: 900 mg daily
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Cernevit-12
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Clarithromycin
Dosage: df 50mg/ml
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Folic Acid
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Isentress
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: df 80/20 mg
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Myambutol
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Nefopam
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-07-16
Olanzapine
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven (Parenteral Nutrition)
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Potassium Chloride
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Prazepam
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Rifabutin
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Viramune
Indication: HIV Infection
Start date: 2012-03-01
End date: 2012-05-01
Other drugs received by patient: Adavat; Propofol
Possible Kaletra side effects in 41 year old female
Reported by a physician from Thailand on 2012-08-13
Patient: 41 year old female
Reactions: Anaemia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine; Zidovudine
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient: male
Reactions: Confusional State, Agitation, Refusal of Treatment by Patient, Malnutrition, Anaemia, Coma, General Physical Health Deterioration, Pyrexia, Convulsion, Apathy, Hepatotoxicity, Diarrhoea, Thrombocytopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Acetaminophen
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Acupan
Dosage: 120 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-16
End date: 2012-07-27
Amikacin
Dosage: 900 mg, unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Bactrim
Dosage: 800 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-13
Cernevit / 01027001 /
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
End date: 2012-08-02
Clarithromycin
Dosage: 500 mg, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Isentress
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-05-01
Kaletra
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Leucovorin Calcium
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Myambutol
Dosage: 2 df, qd
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Olanzapine
Dosage: 1 df, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-01
Perikabiven
Dosage: unk
Indication: Parenteral Nutrition
Start date: 2012-07-10
Potassium Chloride
Dosage: unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Prazepam
Dosage: 1 df, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-10
Rifabutin
Dosage: 150 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2012-07-11
Truvada
Dosage: unk
Administration route: Oral
Indication: HIV Infection
Start date: 2012-03-01
Possible Kaletra side effects in male
Reported by a physician from France on 2012-08-02
Patient: male, weighing 4.7 kg (10.3 pounds)
Reactions: Hypothermia, Foetal Exposure During Pregnancy, Anaemia, Tachycardia, Lactic Acidosis, Foetal Distress Syndrome, Apparent Death, Electroencephalogram Abnormal, Renal Failure, Rash Erythematous, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Kaletra
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Retrovir
Start date: 2012-06-26
End date: 2012-06-29
Retrovir
Indication: Prophylaxis
Start date: 2012-06-26
End date: 2012-06-26
Possible Kaletra side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31
Patient:
Reactions: Jaundice, Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Premature Baby, Anaemia, Foetal Exposure During Pregnancy, Limb Malformation, Ascites, Hydrops Foetalis, Talipes
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in
Reported by a consumer/non-health professional from France on 2012-07-30
Patient:
Reactions: Drug Eruption, Death, Aspartate Aminotransferase Increased, Anaemia, Neutropenia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
Dapsone
Dosage: 100 mg, qd
Indication: Prophylaxis
Start date: 2011-01-15
Epivir
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-06-30
Isentress
Dosage: 800 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-05-30
End date: 2010-08-31
Isoniazid
Dosage: 400 mg, qd
Administration route: Oral
Indication: Tuberculosis
Start date: 2010-05-22
End date: 2010-08-10
Kaletra
Dosage: 20
Administration route: Oral
Indication: HIV Infection
Start date: 2010-11-22
Pyrazinamide
Dosage: 2 g, qd
Administration route: Oral
Indication: Tuberculosis
Start date: 2010-05-22
End date: 2010-07-26
Rifampin
Dosage: 600 mg, qd
Administration route: Oral
Indication: Tuberculosis
Start date: 2010-05-22
End date: 2010-08-10
Viread
Dosage: 300 mg, qd
Administration route: Oral
Indication: HIV Infection
Start date: 2010-05-30
Other drugs received by patient: Bactrim; Leucovorin Calcium; Leucovorin Calcium; Ivermectin; Acyclovir; Ciproflaxacin; Azithromycin; Pyridoxine HCL; Omeprazole
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-27
Patient: male
Reactions: Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Apparent Death, Foetal Distress Syndrome, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Prophylaxis Against HIV Infection
Start date: 2012-06-26
End date: 2012-06-26
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-20
Patient: male
Reactions: Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Apparent Death, Foetal Distress Syndrome, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Prophylaxis Against HIV Infection
Start date: 2012-06-26
End date: 2012-06-26
Retrovir
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-17
Patient: male, weighing 4.7 kg (10.3 pounds)
Reactions: Hypothermia, Tachycardia, Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Electroencephalogram Abnormal, Foetal Distress Syndrome, Apparent Death, Renal Failure, Rash Erythematous, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Kaletra
Indication: Prophylaxis
Start date: 2011-01-01
End date: 2012-06-26
Retrovir
Start date: 2012-06-26
End date: 2012-06-29
Retrovir
Indication: Prophylaxis
Start date: 2012-06-26
End date: 2012-06-26
Possible Kaletra side effects in male
Reported by a physician from France on 2012-07-16
Patient: male
Reactions: Anaemia, Foetal Exposure During Pregnancy, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Foetal Distress Syndrome, Apparent Death, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Maternal Exposure Timing Unspecified
Retrovir
Indication: Prophylaxis Against HIV Infection
Start date: 2012-06-26
End date: 2012-06-26
Possible Kaletra side effects in female
Reported by a consumer/non-health professional from Brazil on 2012-07-05
Patient: female, weighing 53.0 kg (116.6 pounds)
Reactions: Weight Decreased, Vomiting, Nausea, Anaemia, Somnolence, Dengue Fever, Laziness, Fatigue, Ocular Icterus, Asthenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Unspecified Vitamin; Ferrous Sulfate TAB
Possible Kaletra side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28
Patient:
Reactions: Atrial Septal Defect, Jaundice, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Anaemia, Limb Malformation, Ascites, Hydrops Foetalis, Talipes
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in male
Reported by a pharmacist from United States on 2012-06-26
Patient: male, weighing 2.1 kg (4.6 pounds)
Reactions: Ventricular Hypokinesia, Premature Baby, Hyperkalaemia, Colitis Ulcerative, Anaemia, Maternal Exposure During Pregnancy, General Physical Health Deterioration, Toxicity To Various Agents, Cardiac Failure, Electrocardiogram Abnormal, Hypotonia, Abdominal Distension, Bradycardia, Sinoatrial Block, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Kaletra
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2007-05-26
End date: 2007-05-30
Saquinavir
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20
Patient:
Reactions: Jaundice, Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Anaemia, Limb Malformation, Ascites, Hydrops Foetalis, Talipes
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in female
Reported by a physician from Japan on 2012-06-08
Patient: female
Reactions: Caesarean Section, Maternal Exposure During Pregnancy, Anaemia, Delivery
Drug(s) suspected as cause:
Combivir
Dosage: 2iuax per day
Administration route: Oral
Start date: 2011-11-10
Combivir
Dosage: 2iuax per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-09-22
End date: 2011-09-28
Epivir
Dosage: 2iuax per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-09-29
End date: 2011-11-09
Kaletra
Dosage: 4iuax per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-09-22
Retrovir
Dosage: 4iuax per day
Administration route: Oral
Indication: HIV Infection
Start date: 2011-09-29
End date: 2011-11-09
Possible Kaletra side effects in female
Reported by a physician from Botswana on 2012-06-01
Patient: female
Reactions: Anaemia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine + Zidovudine
Possible Kaletra side effects in 27 year old female
Reported by a physician from Japan on 2012-05-30
Patient: 27 year old female
Reactions: Anaemia, Alanine Aminotransferase Increased, Maternal Exposure During Pregnancy, Aspartate Aminotransferase Increased
Drug(s) suspected as cause:
Kaletra
Dosage: 4tab per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2011-03-22
Lamivudine (Epivir Hbv)
Indication: Antiretroviral Therapy
Start date: 2011-12-22
Norvir
Dosage: 100mgd per day
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-06
Retrovir
Indication: Antiretroviral Therapy
Start date: 2011-12-22
Reyataz
Administration route: Oral
Indication: Antiretroviral Therapy
Start date: 2012-03-06
Truvada
Indication: Antiretroviral Therapy
Start date: 2012-02-28
Possible Kaletra side effects in 65 year old male
Reported by a physician from Korea, Republic of on 2012-05-29
Patient: 65 year old male
Reactions: White Blood Cell Count Decreased, Pneumonia, Anaemia, Hepatic Failure, Haemoglobin Decreased, Renal Failure, Diarrhoea, Sepsis, Dizziness, Bone Marrow Failure, Diarrhoea Infectious, Leukopenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Azt(zdv); Megace Suspension 40mg / 240ml; CJ 20% Dextrose Water 0.2g / ML 1000ml; ABC; TS TAB; Cebatrim INJ; Dapsone; Ziagen; Norpine; Combivir; Lamivudine (Epivir Hbv)
Possible Kaletra side effects in female
Reported by a physician from Guinea-Bissau on 2012-04-17
Patient: female
Reactions: Anaemia, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Lamivudine; Abacavir; Cotrim; Folic Acid
Possible Kaletra side effects in female
Reported by a physician from Guinea-Bissau on 2012-04-16
Patient: female
Reactions: Anaemia, Pyrexia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Cotrim; Folic Acid; Abacavir; Lamivudine
Possible Kaletra side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-13
Patient: male, weighing 64.9 kg (142.8 pounds)
Reactions: Vomiting, Nausea, Anaemia, Rectal Haemorrhage, Drug Interaction, Cushing's Syndrome, Blood Potassium Decreased, Oedema Peripheral, Compression Fracture, Thoracic Vertebral Fracture
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient possibly interacting with the suspect drug: Triamcinolone
Indication: Compression Fracture
Start date: 2012-01-01
End date: 2012-01-01
Possible Kaletra side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12
Patient:
Reactions: Jaundice, Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Premature Baby, Anaemia, Foetal Exposure During Pregnancy, Limb Malformation, Ascites, Hydrops Foetalis, Talipes
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Possible Kaletra side effects in 65 year old male
Reported by a physician from Korea, Republic of on 2012-04-09
Patient: 65 year old male
Reactions: White Blood Cell Count Decreased, Pneumonia, Anaemia, Hepatic Failure, Haemoglobin Decreased, Renal Failure, Diarrhoea, Sepsis, Bone Marrow Failure, Diarrhoea Infectious, Leukopenia, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Kaletra
Other drugs received by patient: Norpine; TS TAB; ABC; Dapsone; Combivir; Cebatrim INJ; Lamivudine (Epivir Hbv); Megace Suspension 40mg / 240ml; Azt(zdv); CJ 20% Dextrose Water 0.2g / ML 1000ml; Ziagen
Possible Kaletra side effects in 35 year old female
Reported by a physician from Korea, Republic of on 2012-03-30
Patient: 35 year old female, weighing 55.0 kg (121.0 pounds)
Reactions: Vomiting, Nausea, Anaemia, Premature Labour, Vaginal Haemorrhage
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2010-09-16
End date: 2011-03-21
Kaletra
Administration route: Oral
Start date: 2010-04-07
End date: 2010-09-05
Kaletra
Administration route: Oral
Start date: 2010-09-06
End date: 2010-09-15
Other drugs received by patient: Abacavir; Methylergometrine Maleate; Aceclofenac; Lamivudine (Epivir Hbv); Methylergometrine Maleate; Oxytocin 5IU; Magnesium Hydroxide TAB; Combivir; Ranitidine; Cefminox
Possible Kaletra side effects in 51 year old female
Reported by a physician from Spain on 2012-03-22
Patient: 51 year old female
Reactions: Anaemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
Pegasys
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-28
End date: 2012-02-07
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-28
End date: 2012-02-07
Truvada
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
End date: 2012-02-07
Possible Kaletra side effects in 51 year old female
Reported by a physician from Spain on 2012-03-22
Patient: 51 year old female
Reactions: Drug Ineffective, Anaemia, Haemolytic Anaemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Dosage: 200mg/50mg
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
Peginterferon Alfa-2A
Indication: Product Used FOR Unknown Indication
Start date: 2011-09-28
End date: 2012-02-07
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-28
End date: 2012-02-07
Truvada
Dosage: 200mg/245mg
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
End date: 2012-02-07
Possible Kaletra side effects in 51 year old female
Reported by a physician from Spain on 2012-03-20
Patient: 51 year old female
Reactions: Anaemia, Renal Failure Acute
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kaletra
Dosage: 1 df, unk
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
Pegasys
Start date: 2011-09-28
End date: 2012-02-07
Ribavirin
Administration route: Oral
Indication: Hepatitis C
Start date: 2011-09-28
End date: 2012-02-07
Truvada
Dosage: 1 df, unk
Administration route: Oral
Indication: HIV Infection
Start date: 2008-01-01
End date: 2012-02-07
Page 1 Next >>
|